106 related articles for article (PubMed ID: 23695012)
1. The antiangiogenic properties of sulfated β-cyclodextrins in anticancer formulations incorporating 5-fluorouracil.
Watson CA; Vine KL; Locke JM; Bezos A; Parish CR; Ranson M
Anticancer Drugs; 2013 Aug; 24(7):704-14. PubMed ID: 23695012
[TBL] [Abstract][Full Text] [Related]
2. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
[TBL] [Abstract][Full Text] [Related]
3. Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
Locke JM; Stutchbury TK; Vine KL; Gamble AB; Clingan PR; Bremner JB; Ranson M
Anticancer Drugs; 2009 Oct; 20(9):822-31. PubMed ID: 19606016
[TBL] [Abstract][Full Text] [Related]
4. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
[TBL] [Abstract][Full Text] [Related]
5. CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity.
Vu HN; Miller WJ; O'Connor SA; He M; Schafer PH; Payvandi F; Muller GW; Stirling DI; Libutti SK
J Surg Res; 2010 Nov; 164(1):116-25. PubMed ID: 19726061
[TBL] [Abstract][Full Text] [Related]
6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
7. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
[TBL] [Abstract][Full Text] [Related]
8. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
Nowak-Sliwinska P; Clavel CM; Păunescu E; te Winkel MT; Griffioen AW; Dyson PJ
Mol Pharm; 2015 Aug; 12(8):3089-96. PubMed ID: 26158308
[TBL] [Abstract][Full Text] [Related]
10. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of scopoletin derivatives.
Cai X; Yang J; Zhou J; Lu W; Hu C; Gu Z; Huo J; Wang X; Cao P
Bioorg Med Chem; 2013 Jan; 21(1):84-92. PubMed ID: 23218780
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.
Xu F; Jia Y; Wen Q; Wang X; Zhang L; Zhang Y; Yang K; Xu W
Eur J Med Chem; 2013 Jun; 64():377-88. PubMed ID: 23644219
[TBL] [Abstract][Full Text] [Related]
13. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
Mousa SA; Mohamed S; Wexler EJ; Kerr JS
Anticancer Res; 2005; 25(1A):197-206. PubMed ID: 15816539
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis inhibition and cell cycle arrest induced by treatment with Pseudolarix acid B alone or combined with 5-fluorouracil.
Liu J; Guo W; Xu B; Ran F; Chu M; Fu H; Cui J
Acta Biochim Biophys Sin (Shanghai); 2012 Jun; 44(6):490-502. PubMed ID: 22551583
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.
Reimer CL; Agata N; Tammam JG; Bamberg M; Dickerson WM; Kamphaus GD; Rook SL; Milhollen M; Fram R; Kalluri R; Kufe D; Kharbanda S
Cancer Res; 2002 Feb; 62(3):789-95. PubMed ID: 11830534
[TBL] [Abstract][Full Text] [Related]
17. Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis.
Lin J; Wei L; Xu W; Hong Z; Liu X; Peng J
Mol Med Rep; 2011; 4(6):1283-8. PubMed ID: 21887465
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
20. Diaminothiazoles inhibit angiogenesis efficiently by suppressing Akt phosphorylation.
Thomas SA; Thamkachy R; Ashokan B; Komalam RJ; Sreerekha KV; Bharathan A; Santhoshkumar TR; Rajasekharan KN; Sengupta S
J Pharmacol Exp Ther; 2012 Jun; 341(3):718-24. PubMed ID: 22414853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
